Deena S. Lasheen

1.3k citations

40 papers · 1.1k indexed · h-index 19

Organic Chemistry top 5%
Molecular Biology
Oncology top 10%
Pulmonary and Respiratory Medicine
Computational Theory and Mathematics top 5%

Co-authors: Khaled A. M. Abouzid Rabah A.T. Serya Amal Kamal Abdel‐Aziz Ahmed Esmat Abdel Nasser B. Singab Ahmed M. Mansour Dalal A. Abou El Ella Nahla A. Farag
Topics: Synthesis and biological activity (13 papers)HER2/EGFR in Cancer Research (8 papers)Quinazolinone synthesis and applications (7 papers)
Cited by: Organic Chemistry Toxicology Oncology
Journals: SHILAP Revista de lepidopterologíaScientific Reports Organic Letters
Partner nations: Egypt United States Italy

In The Last Decade

Deena S. Lasheen

37 papers receiving 1.0k citations

Peers

Countries citing papers authored by Deena S. Lasheen

Since Specialization

Citations

This map shows the geographic impact of Deena S. Lasheen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deena S. Lasheen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deena S. Lasheen more than expected).

Fields of papers citing papers by Deena S. Lasheen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deena S. Lasheen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deena S. Lasheen. The network helps show where Deena S. Lasheen may publish in the future.

Co-authorship network of co-authors of Deena S. Lasheen

This figure shows the co-authorship network connecting the top 25 collaborators of Deena S. Lasheen. A scholar is included among the top collaborators of Deena S. Lasheen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deena S. Lasheen. Deena S. Lasheen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Acetylcholine Esterase Inhibition in Alzheimer's Therapy: Spotlight on Quinzolinone Derivatives 2025 ·(unknown),(unknown),Medhat Moussa,(unknown),Ahmed S. Kamel,Deena S. Lasheen,Hanan H. Georgey	0
2	Design, synthesis and biological evaluation of triazolo[1,5-a]pyrimidine derivatives as new antiproliferative agents with multikinase inhibitory activity 2025 ·Bioorganic Chemistry ·(unknown),(unknown),(unknown),(unknown),Tamer M. Ibrahim,Mahmoud M. Elaasser,Hatem A. Abdel‐Aziz,Deena S. Lasheen,Dalal A. Abou El Ella	0
3	FLT3-PROTACs for combating AML resistance: Analytical overview on chimeric agents developed, challenges, and future perspectives 2024 ·European Journal of Medicinal Chemistry ·(unknown),Eman M.E. Dokla,(unknown),Deena S. Lasheen,Dalal A. Abou El Ella	3
4	Design, molecular modelling and synthesis of novel benzothiazole derivatives as BCL-2 inhibitors 2023 ·Scientific Reports ·(unknown),(unknown),(unknown),Deena S. Lasheen,Dalal A. Abou El Ella	3
5	Novel quinazolinone Derivatives: Design, synthesis and in vivo evaluation as potential agents targeting Alzheimer disease 2023 ·Bioorganic Chemistry ·(unknown),(unknown),(unknown),Ahmed S. Kamel,Deena S. Lasheen,Hanan H. Georgey	9
6	Design, synthesis, and biological evaluation of new thieno[2,3- d ] pyrimidine derivatives as targeted therapy for PI3K with molecular modelling study 2021 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·(unknown),Deena S. Lasheen,Khaled A. M. Abouzid	12
7	Novel benzenesulfonamides aryl and arylsulfone conjugates adopting tail/dual tail approaches: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies 2021 ·European Journal of Medicinal Chemistry ·(unknown),Mahmoud F. Abo-Ashour,Andrea Angeli,Alessandro Bonardi,Deena S. Lasheen,(unknown),Alessio Nocentini,Paola Gratteri,Hatem A. Abdel‐Aziz,Claudiu T. Supuran	26
8	3D-QSAR pharmacophore modelling, virtual screening and docking studies for lead discovery of a novel scaffold for VEGFR 2 inhibitors: Design, synthesis and biological evaluation 2019 ·Bioorganic Chemistry ·(unknown),(unknown),Deena S. Lasheen,Nahla A. Farag,Khaled A. M. Abouzid	39
9	Phosphatidylinositol 3 kinase (PI3K) inhibitors as new weapon to combat cancer 2019 ·European Journal of Medicinal Chemistry ·(unknown),Deena S. Lasheen,Khaled A. M. Abouzid	103
10	Chimeric HDAC inhibitors: Comprehensive review on the HDAC‐based strategies developed to combat cancer 2018 ·Medicinal Research Reviews ·(unknown),Deena S. Lasheen,Khaled A. M. Abouzid	122
11	Synthesis and biological evaluation of novel 2-oxo-1,2-dihydroquinoline-4-carboxamide derivatives for the treatment of esophageal squamous cell carcinoma 2018 ·European Journal of Medicinal Chemistry ·(unknown),Joyeeta Roy,(unknown),Dongyao Wang,Urarika Luesakul,Yifeng Chai,Nongnuj Muangsin,Deena S. Lasheen,Dalal A. Abou El Ella,Khaled A. M. Abouzid,Nouri Neamati	12
12	Imidazo[2′,1′:2,3]thiazolo[4,5-d]pyridazinone as a new scaffold of DHFR inhibitors: Synthesis, biological evaluation and molecular modeling study 2018 ·Bioorganic Chemistry ·(unknown),Dalal A. Abou El Ella,Deena S. Lasheen,(unknown),(unknown),Hussein I. El‐Subbagh	24
13	Identification of new pyrrolo[2,3-d]pyrimidines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, biological evaluation and molecular modeling 2018 ·Bioorganic Chemistry ·(unknown),Rabah A.T. Serya,Deena S. Lasheen,Khaled A. M. Abouzid	36
14	Surmounting the resistance against EGFR inhibitors through the development of thieno[2,3-d]pyrimidine-based dual EGFR/HER2 inhibitors 2018 ·European Journal of Medicinal Chemistry ·(unknown),Amal Kamal Abdel‐Aziz,Deena S. Lasheen,Rabah A.T. Serya,Saverio Minucci,Khaled A. M. Abouzid	61
15	Discovery of anilino-furo[2,3- d ]pyrimidine derivatives as dual inhibitors of EGFR/HER2 tyrosine kinase and their anticancer activity 2017 ·European Journal of Medicinal Chemistry ·(unknown),Deena S. Lasheen,Nasser S. M. Ismail,Ahmed Esmat,Ahmed M. Mansour,Abdel Nasser B. Singab,Khaled A. M. Abouzid	34
16	Covalent EGFR Inhibitors: Binding Mechanisms, Synthetic Approaches, and Clinical Profiles 2016 ·Archiv der Pharmazie ·(unknown),Deena S. Lasheen,Khaled A. M. Abouzid	32
17	Design and Synthesis of 4‐Anilinothieno[2,3‐d]pyrimidine‐Based Compounds as Dual EGFR/HER‐2 Inhibitors 2016 ·Archiv der Pharmazie ·(unknown),Deena S. Lasheen,(unknown),Khaled A. M. Abouzid	22
18	Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents 2016 ·Scientific Reports ·(unknown),Rabah A.T. Serya,Deena S. Lasheen,Amal Kamal Abdel‐Aziz,Ahmed Esmat,Ahmed M. Mansour,Abdel Nasser B. Singab,Khaled A. M. Abouzid	150
19	Toward discovery of mutant EGFR inhibitors; Design, synthesis and in vitro biological evaluation of potent 4-arylamino-6-ureido and thioureido-quinazoline derivatives 2016 ·Bioorganic & Medicinal Chemistry ·(unknown),Athanasios Galanis,Zainab M. Doctor,Raymond M. Paranal,Deena S. Lasheen,Nahla A. Farag,Pasi A. Jänne,Khaled A. M. Abouzid	49
20	Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII 2015 ·Bioorganic & Medicinal Chemistry ·Diaa A. Ibrahim,Deena S. Lasheen,(unknown),(unknown),Daniela Vullo,Mariangela Ceruso,Claudiu T. Supuran,Dalal A. Abou El Ella	42

About Deena S. Lasheen

Deena S. Lasheen is a scholar working on Organic Chemistry, Oncology and Molecular Biology, having authored 40 papers that have together received 1.1k indexed citations. Recurring topics across this work include Synthesis and biological activity (13 papers), HER2/EGFR in Cancer Research (8 papers) and Quinazolinone synthesis and applications (7 papers). The work is most often cited by research in Organic Chemistry (627 citations), Toxicology (47 citations) and Oncology (252 citations). Deena S. Lasheen has collaborated with scholars based in Egypt, United States and Italy. Frequent co-authors include Khaled A. M. Abouzid, Rabah A.T. Serya, Amal Kamal Abdel‐Aziz, Ahmed Esmat, Abdel Nasser B. Singab, Ahmed M. Mansour, Dalal A. Abou El Ella, Nahla A. Farag, Saverio Minucci and Claudiu T. Supuran. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Organic Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact